<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">

  <!-- PACE Progress Bar START -->
  
    
<script src="https://raw.githubusercontent.com/HubSpot/pace/v1.0.2/pace.min.js"></script>

    
<link rel="stylesheet" href="https://github.com/HubSpot/pace/raw/master/themes/orange/pace-theme-flash.css">

  
  

  <!-- PACE Progress Bar START -->

  
  <title>Yujie&#39;s Blog</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  
  
  
  
  <meta name="description" content="文章来源：《经济学人》Sep 11th 2021 期 Science &amp; technology 栏目 A new AIDS vaccine heads to clinical trials一种新的艾滋病疫苗进入临床试验 The other pandemic另一种大范围流行病  ![image-20210916111357437](&#x2F;Users&#x2F;chenyujie&amp;#x2">
<meta property="og:type" content="article">
<meta property="og:title" content="Yujie&#39;s Blog">
<meta property="og:url" content="http://example.com/2021/09/16/Day513-The%20Economist/index.html">
<meta property="og:site_name" content="Yujie&#39;s Blog">
<meta property="og:description" content="文章来源：《经济学人》Sep 11th 2021 期 Science &amp; technology 栏目 A new AIDS vaccine heads to clinical trials一种新的艾滋病疫苗进入临床试验 The other pandemic另一种大范围流行病  ![image-20210916111357437](&#x2F;Users&#x2F;chenyujie&amp;#x2">
<meta property="og:locale">
<meta property="article:published_time" content="2021-09-16T03:13:19.303Z">
<meta property="article:modified_time" content="2021-09-16T03:14:46.181Z">
<meta property="article:author" content="Chen Yujie">
<meta name="twitter:card" content="summary">
  
    <link rel="alternate" href="/atom.xml" title="Yujie&#39;s Blog" type="application/atom+xml">
  
  <link rel="icon" href="/css/images/favicon.ico">
  
    <link href="//fonts.googleapis.com/css?family=Source+Code+Pro" rel="stylesheet" type="text/css">
  
  <link href="https://fonts.googleapis.com/css?family=Open+Sans|Montserrat:700" rel="stylesheet" type="text/css">
  <link href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic" rel="stylesheet" type="text/css">
  <link href="https://cdn.bootcss.com/font-awesome/4.6.3/css/font-awesome.min.css" rel="stylesheet">
  <style type="text/css">
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/9749f0/00000000000000000001008f/27/l?subset_id=2&fvd=n5) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/90cf9f/000000000000000000010091/27/l?subset_id=2&fvd=n7) format("woff2");font-weight:500;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/8a5494/000000000000000000013365/27/l?subset_id=2&fvd=n4) format("woff2");font-weight:lighter;font-style:normal;}
    @font-face{font-family:futura-pt;src:url(https://use.typekit.net/af/d337d8/000000000000000000010095/27/l?subset_id=2&fvd=i4) format("woff2");font-weight:400;font-style:italic;}</style>
    
  <link rel="stylesheet" id="athemes-headings-fonts-css" href="//fonts.googleapis.com/css?family=Yanone+Kaffeesatz%3A200%2C300%2C400%2C700&amp;ver=4.6.1" type="text/css" media="all">
  
<link rel="stylesheet" href="/css/style.css">


  
<script src="https://code.jquery.com/jquery-3.1.1.min.js"></script>


  <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="https://netdna.bootstrapcdn.com/bootstrap/3.0.2/css/bootstrap.min.css" >
  <link rel="stylesheet" href="/css/hiero.css" >
  <link rel="stylesheet" href="/css/glyphs.css" >
  
    <link rel="stylesheet" href="/css/vdonate.css" >
  

  <!-- Custom CSS -->
  
<link rel="stylesheet" href="/css/my.css">

  <!-- Google Adsense -->
  
  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  <script>
      (adsbygoogle = window.adsbygoogle || []).push({
          google_ad_client: "ca-pub-0123456789ABCDEF",
          enable_page_level_ads: true
      });
  </script>
  
<meta name="generator" content="Hexo 6.3.0"></head>

<script>
var themeMenus = {};

  themeMenus["/"] = "Home"; 

  themeMenus["/archives"] = "Archives"; 

  themeMenus["/categories"] = "Categories"; 

  themeMenus["/tags"] = "Tags"; 

  themeMenus["/about"] = "About"; 

</script>


  <body data-spy="scroll" data-target="#toc" data-offset="50">


  <header id="allheader" class="site-header" role="banner">
  <div class="clearfix container">
      <div class="site-branding">

          <h1 class="site-title">
            
              <a href="/" title="Yujie&#39;s Blog" rel="home"> Yujie&#39;s Blog </a>
            
          </h1>

          
            <div class="site-description">Welcome to my channel</div>
          
            
          <nav id="main-navigation" class="main-navigation" role="navigation">
            <a class="nav-open">Menu</a>
            <a class="nav-close">Close</a>
            <div class="clearfix sf-menu">

              <ul id="main-nav" class="nmenu sf-js-enabled">
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/">Home</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/archives">Archives</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/categories">Categories</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/tags">Tags</a> </li>
                    
                      <li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-1663"> <a class="" href="/about">About</a> </li>
                    
              </ul>
            </div>
          </nav>


      </div>
  </div>
</header>


  <div id="originBgDiv" style="background: #fff; width: 100%;">

      <div style="max-height:600px; overflow: hidden;  display: flex; display: -webkit-flex; align-items: center;">
        <img id="originBg" width="100%" alt="" src="">
      </div>

  </div>

  <script>
  function setAboutIMG(){
      var imgUrls = "css/images/pose.jpg,https://source.unsplash.com/collection/954550/1920x1080".split(",");
      var random = Math.floor((Math.random() * imgUrls.length ));
      if (imgUrls[random].startsWith('http') || imgUrls[random].indexOf('://') >= 0) {
        document.getElementById("originBg").src=imgUrls[random];
      } else {
        document.getElementById("originBg").src='/' + imgUrls[random];
      }
  }
  bgDiv=document.getElementById("originBgDiv");
  if(location.pathname.match('about')){
    setAboutIMG();
    bgDiv.style.display='block';
  }else{
    bgDiv.style.display='none';
  }
  </script>



  <div id="container">
    <div id="wrap">
            
      <div id="content" class="outer">
        
          <section id="main" style="float:none;"><article id="post-Day513-The Economist" style="width: 66%; float:left;" class="article article-type-post" itemscope itemprop="blogPost" >
  <div id="articleInner" class="clearfix post-1016 post type-post status-publish format-standard has-post-thumbnail hentry category-template-2 category-uncategorized tag-codex tag-edge-case tag-featured-image tag-image tag-template">
    
    
    <div class="article-meta">
      
	Posted on <a href="/2021/09/16/Day513-The%20Economist/" class="article-date">
	  <time datetime="2021-09-16T03:13:19.303Z" itemprop="datePublished">September 16, 2021</time>
	</a>

      
	<span id="busuanzi_container_page_pv">
	  本文总阅读量<span id="busuanzi_value_page_pv"></span>次
	</span>

    </div>
    <div class="article-entry" itemprop="articleBody">
      
        <p>文章来源：《经济学人》Sep 11th 2021 期 Science &amp; technology 栏目</p>
<h1 id="A-new-AIDS-vaccine-heads-to-clinical-trials"><a href="#A-new-AIDS-vaccine-heads-to-clinical-trials" class="headerlink" title="A new AIDS vaccine heads to clinical trials"></a>A new AIDS vaccine heads to clinical trials</h1><p>一种新的艾滋病疫苗进入临床试验</p>
<h6 id="The-other-pandemic"><a href="#The-other-pandemic" class="headerlink" title="The other pandemic"></a>The other pandemic</h6><p>另一种大范围流行病</p>
<p> ![image-20210916111357437](&#x2F;Users&#x2F;chenyujie&#x2F;Library&#x2F;Application Support&#x2F;typora-user-images&#x2F;image-20210916111357437.png)</p>
<h5 id="It-uses-the-same-mRNA-technology-as-some-covid-jabs"><a href="#It-uses-the-same-mRNA-technology-as-some-covid-jabs" class="headerlink" title="It uses the same mRNA technology as some covid jabs"></a>It uses the same mRNA technology as some covid jabs</h5><p>使用了与新冠病毒疫苗相同的mRNA技术</p>
<p><strong>ONE SILVER lining to</strong> the covid-19 pandemic has been t<strong>he speed with which effective vaccines have been developed</strong>. Victims of other pandemics have not been so lucky. <strong>Three decades of attempts</strong> to create a vaccine against HIV, the virus that causes AIDS, <strong>have proved fruitless</strong>. The latest setback came on August 31st, when an experimental vaccine produced by Johnson &amp; Johnson, an American pharmaceutical firm, flunked a clinical trial. <strong>One obstacle is</strong> HIV’s genetic slipperiness. The virus has a <strong>high mutation rate</strong>, which helps it adapt to evade both natural immune systems and artificial vaccines.</p>
<p>covid-19大流行病的一线希望是有效疫苗的研发速度。其他流行病的受害者就没有这么幸运了。三十年来，人们一直试图研制出一种对抗HIV(导致艾滋病的病毒)的疫苗，但都没有成效。最近的一次挫折发生在8月31日，当时美国制药公司强生生产的一种实验性疫苗在临床试验中失败。其中一个障碍是HIV基因的不稳定性。该病毒具有高突变率，这有助于它适应自然免疫系统和人工疫苗。</p>
<p><strong>Undaunted, Moderna</strong>, a firm based in Massachusetts that has recently found fame by quickly coming up with a viable covid-19 jab, <strong>is planning to start human trials of a novel vaccine against HIV.</strong> Its researchers hope that the mRNA technology used to produce its covid-19 jab will succeed against HIV too, by creating a vaccine which the virus cannot easily dodge.</p>
<blockquote>
<p>Undaunted 不屈不挠的</p>
<p>viable 切实可行的</p>
</blockquote>
<p>总部位于马萨诸塞州的Moderna公司百折不挠，正计划开始对一种新型艾滋病毒疫苗进行人体试验。该公司最近因迅速研发出一种可行的covid-19疫苗而出名。该公司的研究人员希望，用于生产covid-19疫苗的mRNA技术也能成功对抗艾滋病毒，创造出一种病毒无法轻易躲避的疫苗。</p>
<p>Moderna’s approach is based <strong>in part</strong> on work by the International AIDS Vaccine Initiative (IAVI), a charity, and Scripps Research, a not-for-profit institute in San Diego. A joint study published in February showed, for the first time in humans, that it is possible to stimulate activity in immune cells called germline B-cells, which can produce things called broadly neutralising antibodies (bnAbs) against HIV.</p>
<p>Moderna的方法部分基于慈善机构国际艾滋病疫苗倡议协会(IAVI)和圣地亚哥非营利机构Scripps Research的工作。今年2月发表的一项联合研究首次表明，人类有可能促进称为生殖B细胞的免疫细胞的活动，这种细胞可以产生针对艾滋病毒的广泛中和抗体(bnAbs)。</p>
<p>Antibodies are proteins produced by the immune system <strong>in response to</strong> infection. Through a process of quick-fire trial and error in response to particular pathogen molecules, known as antigens, the body creates specialised molecules designed <strong>either to</strong> gum up the workings of pathogens, <strong>or to</strong> flag them for destruction by other parts of the immune system. But most antibodies turned out in response to HIV fail to stem the infection <strong>for the same reason</strong> vaccines do—the virus’s rapid mutation rate allows it to evolve to avoid them.</p>
<blockquote>
<p>quick-fire 一连串的</p>
<p>gum up 使运转不灵；搞糟</p>
</blockquote>
<p>抗体是免疫系统对感染作出反应而产生的蛋白质。通过对特定病原体分子(即抗原)的一连串试验和错误反应过程，人体产生了专门的分子，这些分子要么破坏病原体的工作，或者标记它们以供免疫系统的其他部分破坏。但大多数抗体对艾滋病毒的反应都未能阻止感染，原因与疫苗相同——病毒的快速突变率使其进化以避免感染。</p>
<p><strong>As their name suggests</strong>, bnAbs <strong>are less susceptible to</strong> such countermeasures. In the case of HIV, the antigen they recognise is part of a viral protein called gp120. This is the means by which HIV particles “dock” with their target cells prior to infecting them. The part of the protein that does the docking is so well tailored that almost any mutation will make it less effective. Since gp120 is trapped in an evolutionary corner, it is a desirable target for a vaccine.</p>
<blockquote>
<p>countermeasure 对策</p>
</blockquote>
<p>顾名思义，bnAbs不太容易受到此类对策的影响。就HIV而言，它们识别的抗原是一种叫做gp120的病毒蛋白的一部分。这是HIV粒子在感染目标细胞之前与目标细胞“对接”的方法。蛋白质中进行对接的部分经过了精心剪裁，几乎任何突变都会降低对接的效率。由于gp120被困在进化的角落，它是一个理想的疫苗靶点。</p>
<p><strong>Germline B-cells are diverse but rare.</strong> Each carries the blueprint of an antibody, and stands ready to do two things when alerted to the presence of a pathogen. <strong>The first is a process called somatic hypermutation</strong>, which generates daughter cells capable of producing many slightly different versions of that antibody. <strong>The second is clonal expansion,</strong> in which cells carrying the most successful of these variants multiply to deal with the infection.</p>
<p>生殖B细胞种类繁多，但数量稀少。每个人都携带着抗体的蓝图，并随时准备做两件事，以应对病原体的出现。第一个是一个被称为体细胞高频突变的过程，它产生的子细胞能够产生许多不同版本的抗体。第二种是克隆扩增，即携带这些变异中最成功的细胞增殖以应对感染。</p>
<p>The study conducted by IAVI and Scripps used a small engineered protein called eOD-GT8 60mer as an antigen. This protein resembles the cell-docking part of gp120. <strong>Crucially</strong>, empirical work in both mice and humans has shown that it also stimulates somatic hypermutation in germline B-cells carrying a broadly neutralising antibody called VRC01. <strong>That makes it a promising basis for a vaccine.</strong></p>
<p>IAVI和Scripps进行的这项研究使用了一种名为eOD-GT8 60mer的小型工程蛋白作为抗原。这种蛋白质类似于gp120的细胞对接部分。至关重要的是，对小鼠和人类的实验研究表明，它还会促进携带一种广泛中和抗体VRC01的生殖系B细胞的体细胞高频突变。这使得它成为研制疫苗的一个有希望的基础。</p>
<p>The problem with this approach is that eOD-GT8 60mer is slow and expensive to make. Which is where Moderna’s technology comes in. mRNA is the messenger molecule that carries, from a cell’s chromosomes, instructions which tell that cell how to make particular proteins. Instead of carrying eOD-GT8 60mer itself, Moderna’s vaccine contains the mRNA instructions on how to make it, and leaves the job of production to the body’s own cells. Once the molecule enters the bloodstream, it should stimulate the VRC01-carrying germline B-cells to do their stuff. After that, booster shots employing mRNAs for other small antigenic proteins will be used to guide the process of hypermutation in the right direction.</p>
<p>这种方法的问题是eOD-GT8 60mer制造速度缓慢且昂贵。而这正是Moderna的技术发挥作用的地方。mRNA是一种信使分子，它携带细胞染色体上的指令，告诉细胞如何制造特定的蛋白质。Moderna的疫苗本身没有携带eOD-GT8 60mer，而是包含了如何制造它的mRNA指令，并将生产工作留给了身体自身的细胞。一旦这种分子进入血液，它应该会刺激携带VRC01的生殖系B细胞发挥作用。在此之后，利用mRNA对其他小抗原蛋白进行增强注射，以引导高突变过程朝着正确的方向发展。</p>
<p>The trial is an early one, designed to test safety and prove the principle. It is testing two approaches. One uses only the mRNA for eOD-GT8 60mer. The other adds mRNA for one of the small, guiding antigens to the shot. It will begin in America later this month, with 56 people. Trials in Rwanda and South Africa should follow shortly after. (UNAIDS, the body charged by the United Nations with combating HIV, estimates that two-thirds of the 38m people infected with the virus by the end of 2020 were in Africa.)</p>
<p>这是一个早期的试验，旨在测试安全性并证明原理。它正在测试两种方法。一个只使用eOD-GT8 60mer的mRNA。另一种是为其中一种小抗原添加mRNA，引导抗原进入注射。它将于本月晚些时候在美国开始，有56人参加。卢旺达和南非的试验也将很快进行。(联合国负责抗击艾滋病的机构联合国艾滋病规划署(UNAIDS)估计，到2020年底，3800万艾滋病毒感染者中有三分之二在非洲。)</p>
<p>The results from the American trial are expected in 2023. Beyond that, the timeline is less clear. Mark Feinberg, IAVI’s boss, citing how difficult HIV vaccine development still is, does not want people thinking that “just because the covid vaccines were developed using RNA technology in less than a year we’re going to have an HIV vaccine in less than a year”. After three decades of waiting, though, a little more patience is not too much to ask. ■</p>
<p>美国的试验结果预计将于2023年公布。除此之外，时间表就不那么明确了。国际艾滋病疫苗倡议协会的主席Mark Feinberg指出，艾滋病毒疫苗的研发仍然非常困难，他不希望人们认为“仅仅因为利用RNA技术在不到一年的时间里研出了新冠病毒疫苗，我们就会在不到一年的时间里研制出艾滋病毒疫苗”。不过，在30年的等待之后，我们需要再多一点耐心。■</p>

      
    </div>
    <footer class="entry-meta entry-footer">
      
      
      
        <div id="donation_div"></div>


<script src="/js/vdonate.js"></script>

<script>
var a = new Donate({
  title: '如果觉得我的文章对您有用，请随意打赏。您的支持将鼓励我继续创作!', // 可选参数，打赏标题
  btnText: 'Donate', // 可选参数，打赏按钮文字
  el: document.getElementById('donation_div'),
  wechatImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/WeChanQR.png',
  alipayImage: 'https://raw.githubusercontent.com/iTimeTraveler/iTimeTraveler.github.io/site/source/about/donate/images/AliPayQR.jpg'
});
</script>
      
            
      
        
	<div id="comment">
		<!-- 来必力City版安装代码 -->
		<div id="lv-container" data-id="city" data-uid="MTAyMC8yOTQ4MS82MDQ5">
		<script type="text/javascript">
		   (function(d, s) {
		       var j, e = d.getElementsByTagName(s)[0];

		       if (typeof LivereTower === 'function') { return; }

		       j = d.createElement(s);
		       j.src = 'https://cdn-city.livere.com/js/embed.dist.js';
		       j.async = true;

		       e.parentNode.insertBefore(j, e);
		   })(document, 'script');
		</script>
		<noscript>为正常使用来必力评论功能请激活JavaScript</noscript>
		</div>
		<!-- City版安装代码已完成 -->
	</div>


      
    </footer>
  </div>
  
    
<nav id="article-nav">
  
    <a href="/2021/09/17/Day514-The%20Economist/" id="article-nav-newer" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Newer</strong>
      <div class="article-nav-title">
        
          (no title)
        
      </div>
    </a>
  
  
    <a href="/2021/09/15/Day512-The%20Economist/" id="article-nav-older" class="article-nav-link-wrap">
      <strong class="article-nav-caption">Older</strong>
      <div class="article-nav-title"></div>
    </a>
  
</nav>

  
</article>

<!-- Table of Contents -->

  <aside id="sidebar">
    <div id="toc" class="toc-article" style="overflow-y: scroll; max-width: 28%;">
    <strong class="toc-title">Contents</strong>
    
      <ol class="nav"><li class="nav-item nav-level-1"><a class="nav-link" href="#A-new-AIDS-vaccine-heads-to-clinical-trials"><span class="nav-number">1.</span> <span class="nav-text">A new AIDS vaccine heads to clinical trials</span></a><ol class="nav-child"><li class="nav-item nav-level-6"><a class="nav-link" href="#The-other-pandemic"><span class="nav-number">1.0.0.0.0.1.</span> <span class="nav-text">The other pandemic</span></a></li></ol></li><li class="nav-item nav-level-5"><a class="nav-link" href="#It-uses-the-same-mRNA-technology-as-some-covid-jabs"><span class="nav-number">1.0.0.0.1.</span> <span class="nav-text">It uses the same mRNA technology as some covid jabs</span></a></li></ol></li></ol></li></ol></li></ol></li></ol>
    
    </div>
  </aside>
</section>
        
      </div>
      <footer id="footer" class="site-footer">
  

  <div class="clearfix container">
      <div class="site-info">
	      &copy; 2023 Yujie&#39;s Blog All Rights Reserved.
          
            <span id="busuanzi_container_site_uv">
              本站访客数<span id="busuanzi_value_site_uv"></span>人次  
              本站总访问量<span id="busuanzi_value_site_pv"></span>次
            </span>
          
      </div>
      <div class="site-credit">
        Theme by <a href="https://github.com/iTimeTraveler/hexo-theme-hiero" target="_blank">hiero</a>
      </div>
  </div>
</footer>


<!-- min height -->

<script>
    var contentdiv = document.getElementById("content");

    contentdiv.style.minHeight = document.body.offsetHeight - document.getElementById("allheader").offsetHeight - document.getElementById("footer").offsetHeight + "px";
</script>

<!-- Custome JS -->

<script src="/js/my.js"></script>

    </div>
    <!-- <nav id="mobile-nav">
  
    <a href="/" class="mobile-nav-link">Home</a>
  
    <a href="/archives" class="mobile-nav-link">Archives</a>
  
    <a href="/categories" class="mobile-nav-link">Categories</a>
  
    <a href="/tags" class="mobile-nav-link">Tags</a>
  
    <a href="/about" class="mobile-nav-link">About</a>
  
</nav> -->
    

<!-- mathjax config similar to math.stackexchange -->

<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    tex2jax: {
      inlineMath: [ ['$','$'], ["\\(","\\)"] ],
      processEscapes: true
    }
  });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        skipTags: ['script', 'noscript', 'style', 'textarea', 'pre', 'code']
      }
    });
</script>

<script type="text/x-mathjax-config">
    MathJax.Hub.Queue(function() {
        var all = MathJax.Hub.getAllJax(), i;
        for(i=0; i < all.length; i += 1) {
            all[i].SourceElement().parentNode.className += ' has-jax';
        }
    });
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>



  
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.css">

  
<script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/2.1.5/jquery.fancybox.min.js"></script>




<script src="/js/scripts.js"></script>


<script src="https://stackpath.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>


<script src="/js/main.js"></script>








  <div style="display: none;">
    <script src="https://s95.cnzz.com/z_stat.php?id=1260716016&web_id=1260716016" language="JavaScript"></script>
  </div>



	<script async src="https://dnqof95d40fo6.cloudfront.net/atw7f8.js">
	</script>






  </div>

  <a id="rocket" href="#top" class=""></a>
  <script type="text/javascript" src="/js/totop.js" async=""></script>
</body>
</html>
